The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.


Updates from The Motley Fool

Latest updates on Mylan from Fool.com.  The Fool has written over 200 articles on Mylan.
Last Week's Best Healthcare ETF

It was another good week to be a healthcare investor, as many of the most popular exchange-traded...

Last Week's Best Healthcare ETF

Image source: TBIT via Pixabay. After a tumultuous start to the year, investors in the stock mark...



Stock Performance

View Interactive MYL Charts
Sponsored by

Key Data Points

Primary metrics and data points about Mylan.
Current Price: $36.31
Prev Close: $35.99
Open: $36.31
Bid: $36.29
Ask: $36.33
Day's Range: $36.23 - $36.66
52wk Range: $33.60 - $55.50
Volume: 260,081
Avg Vol 6,414,837
Market Cap: $18B
P/E (ttm): 71.98
EPS (ttm): $0.50
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Mylan.
CAPS Rating 3 out of 5
 
653 Outperform
47 Underperform
CAPS All Stars
 
159 Outperform
10 Underperform

How do you think Mylan will perform against the market?



You pick for Mylan is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Heather Bresch, CEO

74% Approve

Based on 90 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Mylan.

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers